Original Research
Published on 03 Oct 2019
The Immune-Modulator Pidotimod Affects the Metabolic Profile of Exhaled Breath Condensate in Bronchiectatic Patients: A Metabolomics Pilot Study
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.01115
- 5,540 views
- 10 citations